{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:42:08Z","timestamp":1790628128652,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/nrc.2017.111","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T09:34:46Z","timestamp":1515144886000},"page":"103-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Autoimmunity checkpoints as therapeutic targets in B cell malignancies"],"prefix":"10.1038","volume":"18","author":[{"given":"Markus","family":"M\u00fcschen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"BFnrc2017111_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751\u2013758 (1996).","journal-title":"Nature"},{"key":"BFnrc2017111_CR2","first-page":"250","volume-title":"73 Verh. Ges. Dtsch. Naturforsch. Aerzte","author":"P Ehrlich","year":"1906","unstructured":"Ehrlich, P. Die Schutzstoffe des Blutes. 73 Verh. Ges. Dtsch. Naturforsch. Aerzte 1, 250\u2013275; English translation available in: Ehrlich, P. in Collected Studies on Immunity (ed. Bolduan, C.) 364\u2013389 (Wiley, 1906)."},{"key":"BFnrc2017111_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/1811419a0","volume":"181","author":"GJ Nossal","year":"1958","unstructured":"Nossal, G. J. & Lederberg, J. Antibody production by single cells. Nature 181, 1419\u20131420 (1958).","journal-title":"Nature"},{"key":"BFnrc2017111_CR4","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.8281","volume-title":"The Clonal Selection Theory of Acquired Immunity","author":"FM Burnet","year":"1959","unstructured":"Burnet, F. M. The Clonal Selection Theory of Acquired Immunity (Cambridge Univ. Press, 1959)."},{"key":"BFnrc2017111_CR5","doi-asserted-by":"publisher","first-page":"a007146","DOI":"10.1101\/cshperspect.a007146","volume":"4","author":"R Pelanda","year":"2012","unstructured":"Pelanda, R. & Torres, R. M. Central B-cell tolerance: where selection begins. Cold Spring Harb. Perspect. Biol. 4, a007146 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"BFnrc2017111_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","volume":"90","author":"KP Lam","year":"1997","unstructured":"Lam, K. P., K\u00fchn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073\u20131083 (1997).","journal-title":"Cell"},{"key":"BFnrc2017111_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","volume":"117","author":"M Kraus","year":"2004","unstructured":"Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Ig\u03b1\/\u03b2 heterodimer. Cell 117, 787\u2013800 (2004).","journal-title":"Cell"},{"key":"BFnrc2017111_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","volume":"139","author":"L Srinivasan","year":"2009","unstructured":"Srinivasan, L. et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139, 573\u2013586 (2009).","journal-title":"Cell"},{"key":"BFnrc2017111_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/337562a0","volume":"337","author":"DA Nemazee","year":"1989","unstructured":"Nemazee, D. A. & B\u00fcrki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562\u2013566 (1989).","journal-title":"Nature"},{"key":"BFnrc2017111_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.20042101","volume":"201","author":"N Feldhahn","year":"2005","unstructured":"Feldhahn, N. et al. Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells. J. Exp. Med. 201, 1837\u20131852 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR11","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1128\/MCB.18.9.5219","volume":"9","author":"H Lee","year":"1998","unstructured":"Lee, H. et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 9, 5219\u20135228 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc2017111_CR12","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","volume":"110","author":"C Mancao","year":"2007","unstructured":"Mancao, C. & Hammerschmidt, W. Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110, 3715\u20133721 (2007).","journal-title":"Blood"},{"key":"BFnrc2017111_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1071489","volume":"297","author":"M Jain","year":"2002","unstructured":"Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science. 297, 102\u2013104 (2002).","journal-title":"Science."},{"key":"BFnrc2017111_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","volume":"297","author":"IB Weinstein","year":"2002","unstructured":"Weinstein, I. B. Addiction to oncogenes \u2014 the Achilles heal of cancer. Science 297, 63\u201364 (2002).","journal-title":"Science"},{"key":"BFnrc2017111_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88\u201392 (2010).","journal-title":"Nature"},{"key":"BFnrc2017111_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116\u2013120 (2012).","journal-title":"Nature"},{"key":"BFnrc2017111_CR17","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","volume":"111","author":"L Chen","year":"2008","unstructured":"Chen, L. et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 111, 2230\u20132237 (2008).","journal-title":"Blood"},{"key":"BFnrc2017111_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd, J. C. et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 369, 32\u201342 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507\u2013516 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","volume":"370","author":"AK Gopal","year":"2014","unstructured":"Gopal, A. K. et al. PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma. N. Engl. J. Med. 370, 1008\u20131018 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature14231","volume":"521","author":"Z Chen","year":"2015","unstructured":"Chen, Z. et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukemia. Nature 521, 357\u2013361 (2015).","journal-title":"Nature"},{"key":"BFnrc2017111_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm.4062","volume":"22","author":"S Shojaee","year":"2016","unstructured":"Shojaee, S. et al. PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nat. Med. 22, 379\u2013387 (2016).","journal-title":"Nat. Med."},{"key":"BFnrc2017111_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","volume":"28","author":"S Shojaee","year":"2015","unstructured":"Shojaee, S. et al. Erk negative feedback control enables pre-B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia. Cancer Cell 28, 114\u2013128 (2015).","journal-title":"Cancer Cell"},{"key":"BFnrc2017111_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/324579a0","volume":"324","author":"N Sakaguchi","year":"1986","unstructured":"Sakaguchi, N. & Melchers, F. Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. Nature 324, 579\u2013582 (1986).","journal-title":"Nature"},{"key":"BFnrc2017111_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/ni959","volume":"9","author":"K Ohnishi","year":"2003","unstructured":"Ohnishi, K. & Melchers, F. The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 9, 849\u2013856 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnrc2017111_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ni.1903","volume":"8","author":"R Ubelhart","year":"2010","unstructured":"Ubelhart, R. et al. N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat. Immunol. 8, 759\u2013765 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrc2017111_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20052217","volume":"203","author":"GC Ippolito","year":"2006","unstructured":"Ippolito, G. C. et al. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J. Exp. Med. 203, 1567\u20131578 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1074-7613(01)00131-5","volume":"14","author":"Y Minegishi","year":"2001","unstructured":"Minegishi, Y. & Conley, M. E. Negative selection at the pre-BCR checkpoint elicited by human mu heavy chains with unusual CDR3 regions. Immunity 14, 631\u2013641 (2001).","journal-title":"Immunity"},{"key":"BFnrc2017111_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1126\/science.1157533","volume":"321","author":"RA Keenan","year":"2008","unstructured":"Keenan, R. A. et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321, 696\u2013699 (2008).","journal-title":"Science"},{"issue":"4","key":"BFnrc2017111_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/eji.201444917","volume":"45","author":"Weicheng Ren","year":"2015","unstructured":"Ren, W. et al. Surrogate light chain is required for central and peripheral B-cell tolerance and inhibits anti-DNA antibody production by marginal zone B cells. Eur. J. Immunol. 4, 1228\u20131237.","journal-title":"European Journal of Immunology"},{"key":"BFnrc2017111_CR31","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1038\/ncomms8077","volume":"6","author":"O Grimsholm","year":"2015","unstructured":"Grimsholm, O. et al. Absence of surrogate light chain results in spontaneous autoreactive germinal centres expanding V(H)81X-expressing B cells. Nat. Commun. 6, 7077 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrc2017111_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1084\/jem.177.4.1009","volume":"177","author":"SL Tiegs","year":"1993","unstructured":"Tiegs, S. L., Russell, D. M. & Nemazee, D. Receptor editing in self-reactive bone marrow B. cells. J. Exp. Med. 177, 1009\u20131020 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"BFnrc2017111_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/338383b0","volume":"338","author":"M Reth","year":"1989","unstructured":"Reth, M. Antigen receptor tail clue. Nature 338, 383\u2013384 (1989).","journal-title":"Nature"},{"key":"BFnrc2017111_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ni893","volume":"4","author":"K Saijo","year":"2003","unstructured":"Saijo, K. et al. Essential role of Src-family protein tyrosine kinases in NF-\u03baB activation during B cell development. Nat. Immunol. 4, 274\u2013279 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnrc2017111_CR36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/378298a0","volume":"378","author":"M Turner","year":"1995","unstructured":"Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298\u2013302 (1995).","journal-title":"Nature"},{"key":"BFnrc2017111_CR37","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1128\/MCB.14.11.7306","volume":"11","author":"A Hata","year":"1994","unstructured":"Hata, A., Sabe, H., Kurosaki, T., Takata, M. & Hanafusa, H. Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol. Cell. Biol. 11, 7306\u20137313 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc2017111_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/j.1460-2075.1993.tb05659.x","volume":"12","author":"M Sieh","year":"1993","unstructured":"Sieh, M., Bolen, J. B. & Weiss, A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 12, 315\u2013321 (1993).","journal-title":"EMBO J"},{"key":"BFnrc2017111_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.179.5.1725","volume":"179","author":"T Kurosaki","year":"1994","unstructured":"Kurosaki, T. et al. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179, 1725\u20131729 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1097-2765(02)00739-6","volume":"5","author":"V Rolli","year":"2002","unstructured":"Rolli, V. et al. Amplification of B cell antigen receptor signaling by a Syk\/ITAM positive feedback loop. Mol. Cell 5, 1057\u20131069 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrc2017111_CR41","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/emboj.2012.169","volume":"31","author":"S K\u00f6nigsberger","year":"2012","unstructured":"K\u00f6nigsberger, S. et al. Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state. EMBO J. 31, 3363\u20133374 (2012).","journal-title":"EMBO J."},{"key":"BFnrc2017111_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20030615","volume":"198","author":"R Kersseboom","year":"2003","unstructured":"Kersseboom, R. et al. Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J. Exp. Med. 198, 91\u201398 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR43","doi-asserted-by":"publisher","first-page":"13266","DOI":"10.1073\/pnas.0505196102","volume":"102","author":"N Feldhahn","year":"2005","unstructured":"Feldhahn, N. et al. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc. Natl Acad. Sci. USA 102, 13266\u201313271 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2017111_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1074-7613(00)80130-2","volume":"11","author":"H Jumaa","year":"1999","unstructured":"Jumaa, H. et al. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11, 547\u2013554 (1999).","journal-title":"Immunity"},{"key":"BFnrc2017111_CR45","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0960-9822(03)00491-3","volume":"13","author":"T Egawa","year":"2003","unstructured":"Egawa, T. et al. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr. Biol. 13, 1252\u20131258 (2003).","journal-title":"Curr. Biol."},{"key":"BFnrc2017111_CR46","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.188.7.1287","volume":"188","author":"A Hashimoto","year":"1998","unstructured":"Hashimoto, A. et al. Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188, 1287\u20131295 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1084\/jem.189.1.179","volume":"189","author":"R Clynes","year":"1999","unstructured":"Clynes, R. et al. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189, 179\u2013185 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.20042251","volume":"201","author":"S Yurasov","year":"2005","unstructured":"Yurasov, S. et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201, 703\u2013711 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR49","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20042321","volume":"201","author":"J Samuels","year":"2005","unstructured":"Samuels, J., Ng, Y. S., Coupillaud, C., Paget, D. & Meffre, E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201, 1659\u20131667 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR50","doi-asserted-by":"publisher","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","volume":"3","author":"F Ramadani","year":"2010","unstructured":"Ramadani, F. et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3, ra60 (2010).","journal-title":"Sci. Signal."},{"issue":"5","key":"BFnrc2017111_CR51","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.immuni.2011.10.011","volume":"35","author":"Shannon\u00a0K. O'Neill","year":"2011","unstructured":"O'Neill, S. K. et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35, 746\u2013756.","journal-title":"Immunity"},{"key":"BFnrc2017111_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.20021101","volume":"197","author":"A Suzuki","year":"2003","unstructured":"Suzuki, A. et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197, 657\u2013667 (2003).","journal-title":"J. Exp. Med."},{"issue":"9","key":"BFnrc2017111_CR53","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","volume":"124","author":"Marie-C\u00e9line Deau","year":"2014","unstructured":"Deau, M. C. et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J. Clin. Invest. 124, 3923\u20133928.","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"BFnrc2017111_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/cr.2008.284","volume":"19","author":"Shuhua Cheng","year":"2008","unstructured":"Cheng, S. et al. BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten. Cell Res. 19, 196\u2013207.","journal-title":"Cell Research"},{"key":"BFnrc2017111_CR55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.20091673","volume":"207","author":"SL Rowland","year":"2010","unstructured":"Rowland, S. L., DePersis, C. L., Torres, R. M. & Pelanda, R. Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation. J. Exp. Med. 207, 607\u2013621 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR56","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ni.1785","volume":"10","author":"M Mandal","year":"2010","unstructured":"Mandal, M. et al. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat. Immunol. 10, 1110\u20131117 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrc2017111_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2008.02.015","volume":"28","author":"T Yasuda","year":"2008","unstructured":"Yasuda, T. et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28, 499\u2013508 (2008).","journal-title":"Immunity"},{"key":"BFnrc2017111_CR58","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1099\/vir.0.2008\/001461-0","volume":"89","author":"LJ Anderson","year":"2008","unstructured":"Anderson, L. J. & Longnecker, R. EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK\/MAPK pathway. J. Gen. Virol. 89, 1563\u20131568 (2008).","journal-title":"J. Gen. Virol."},{"key":"BFnrc2017111_CR59","doi-asserted-by":"publisher","first-page":"E2797","DOI":"10.1073\/pnas.1402159111","volume":"111","author":"LS Teodorovic","year":"2014","unstructured":"Teodorovic, L. S. et al. Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies. Proc. Natl Acad. Sci. USA 111, E2797\u2013E2806 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2017111_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/ni.2016","volume":"12","author":"A Limnander","year":"2011","unstructured":"Limnander, A. et al. STIM1, PKC-\u03b4 and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat. Immunol. 12, 425\u2013433 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrc2017111_CR61","doi-asserted-by":"publisher","first-page":"19523","DOI":"10.1074\/jbc.M314273200","volume":"279","author":"B Guilbault","year":"2004","unstructured":"Guilbault, B. & Kay, R. J. RasGRP1 sensitizes an immature B cell line to antigen receptor-induced apoptosis. J. Biol. Chem. 279, 19523\u201319530 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrc2017111_CR62","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/416860a","volume":"416","author":"I Mecklenbrauker","year":"2002","unstructured":"Mecklenbrauker, I., Saijo, K., Zheng, N. Y., Leitges, M. & Tarakhovsky, A. Protein kinase C\u03b4 controls self-antigen-induced B-cell tolerance. Nature 416, 860\u2013865 (2002).","journal-title":"Nature"},{"key":"BFnrc2017111_CR63","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.exphem.2008.09.008","volume":"37","author":"SL Stang","year":"2009","unstructured":"Stang, S. L. et al. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Exp. Hematol. 37, 122\u2013134 (2009).","journal-title":"Exp. Hematol."},{"key":"BFnrc2017111_CR64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1084\/jem.20030411","volume":"198","author":"A Enders","year":"2003","unstructured":"Enders, A. et al. Loss of the proapoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198, 1119\u20131126 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR65","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","volume":"22","author":"F Luciano","year":"2003","unstructured":"Luciano, F. et al. Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22, 6785\u20136793 (2003).","journal-title":"Oncogene"},{"key":"BFnrc2017111_CR66","doi-asserted-by":"publisher","first-page":"18811","DOI":"10.1074\/jbc.M301010200","volume":"278","author":"R Ley","year":"2003","unstructured":"Ley, R., Balmanno, K., Hadfield, K., Weston, C. & Cook, S. J. Activation of the ERK1\/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein Bim. J. Biol. Chem. 278, 18811\u201318816 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrc2017111_CR67","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1084\/jem.186.12.2013","volume":"186","author":"M Turner","year":"1997","unstructured":"Turner, M. et al. Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J. Exp. Med. 186, 2013\u20132021 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1074-7613(00)80124-7","volume":"11","author":"C Pan","year":"1999","unstructured":"Pan, C., Baumgarth, N. & Parnes, J. R. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 11, 495\u2013506 (1999).","journal-title":"Immunity"},{"key":"BFnrc2017111_CR69","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2017.03.014","volume":"46","author":"P Gurung","year":"2017","unstructured":"Gurung, P. et al. Tyrosine kinase SYK licenses MyD88 adaptor protein to instigate IL-1\u03b1-mediated inflammatory disease. Immunity 46, 635\u2013648 (2017).","journal-title":"Immunity"},{"key":"BFnrc2017111_CR70","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175\u20131188 (2014).","journal-title":"Cell"},{"key":"BFnrc2017111_CR71","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/emboj\/17.9.2584","volume":"17","author":"S Latour","year":"1998","unstructured":"Latour, S., Zhang, J., Siraganian, R. P. & Veillette, A. A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signaling. EMBO J. 17, 2584\u20132595 (1998).","journal-title":"EMBO J."},{"key":"BFnrc2017111_CR72","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","volume":"100","author":"L Chen","year":"2002","unstructured":"Chen, L. et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100, 4609\u20134614 (2002).","journal-title":"Blood"},{"key":"BFnrc2017111_CR73","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20150537","volume":"213","author":"A Getahun","year":"2006","unstructured":"Getahun, A., Beavers, N. A., Larson, S. R., Shlomchik, M. J. & Cambier, J. C. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J. Exp. Med. 213, 751\u2013769 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR74","doi-asserted-by":"crossref","unstructured":"Hug, E., Hobeika, E., Reth, M. & Jumaa, H. Inducible expression of hyperactive Syk in B cells activates Blimp-1-dependent terminal differentiation. Oncogene 33, 3730\u20133741.","DOI":"10.1038\/onc.2013.326"},{"issue":"9","key":"BFnrc2017111_CR75","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/eji.201040521","volume":"40","author":"Rogier Kersseboom","year":"2010","unstructured":"Kersseboom, R. et al. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells. Eur. J. Immunol. 40, 2643\u20132654.","journal-title":"European Journal of Immunology"},{"key":"BFnrc2017111_CR76","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1084\/jem.20040168","volume":"199","author":"BF Hoyer","year":"2004","unstructured":"Hoyer, B. F. et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice. J. Exp. Med. 199, 1577\u20131584 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR77","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-08-2690","volume":"69","author":"O Bailet","year":"2009","unstructured":"Bailet, O. et al. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res. 69, 2748\u20132756 (2009).","journal-title":"Cancer Res."},{"key":"BFnrc2017111_CR78","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005).","journal-title":"Nature"},{"key":"BFnrc2017111_CR79","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593\u2013602 (1997).","journal-title":"Cell"},{"key":"BFnrc2017111_CR80","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI40535","volume":"120","author":"A Alimonti","year":"2010","unstructured":"Alimonti, A. et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120, 681\u2013693 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrc2017111_CR81","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638\u2013642 (2006).","journal-title":"Nature"},{"key":"BFnrc2017111_CR82","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.1900951","volume":"251","author":"B Rocha","year":"1991","unstructured":"Rocha, B. & von Boehmer, H. Peripheral selection of the T cell repertoire. Science 251, 1225\u20131228 (1991).","journal-title":"Science"},{"issue":"7194","key":"BFnrc2017111_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature06933","volume":"453","author":"Wei Guo","year":"2008","unstructured":"Guo, W. et al. Multi-genetic events collaboratively contribute to Pten-null leukemia stem-cell formation. Nature 453, 529\u2013533.","journal-title":"Nature"},{"key":"BFnrc2017111_CR84","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20030729","volume":"198","author":"T Tretter","year":"2003","unstructured":"Tretter, T., Ross, A. E., Dordai, D. I. & Desiderio, S. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J. Exp. Med. 198, 1863\u20131873 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR85","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20031637","volume":"199","author":"F Klein","year":"2004","unstructured":"Klein, F. et al. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells. J. Exp. Med. 199, 673\u2013685 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR86","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1128\/JVI.74.19.9115-9124.2000","volume":"74","author":"M Merchant","year":"2000","unstructured":"Merchant, M., Caldwell, R. G. & Longnecker, R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74, 9115\u20139124 (2000).","journal-title":"J. Virol."},{"key":"BFnrc2017111_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1084\/jem.192.1.11","volume":"192","author":"BS Lee","year":"2000","unstructured":"Lee, B. S., Alvarez, X., Ishido, S., Lackner, A. A. & Jung, J. U. Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J. Exp. Med. 192, 11\u201321 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR88","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrd3937","volume":"12","author":"RM Young","year":"2013","unstructured":"Young, R. M. & Staudt, L. M. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat. Rev. Drug Discov. 12, 229\u2013243 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrc2017111_CR89","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1182\/blood-2015-01-567842","volume":"125","author":"M M\u00fcschen","year":"2015","unstructured":"M\u00fcschen, M. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia. Blood 125, 3688\u20133693 (2015).","journal-title":"Blood"},{"key":"BFnrc2017111_CR90","doi-asserted-by":"publisher","first-page":"ra116","DOI":"10.1126\/scisignal.aaf3949","volume":"9","author":"MF Erasmus","year":"2016","unstructured":"Erasmus, M. F. et al. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia. Sci. Signal. 9, ra116 (2016).","journal-title":"Sci. Signal."},{"key":"BFnrc2017111_CR91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","volume":"27","author":"H Geng","year":"2015","unstructured":"Geng, H. et al. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. Cancer Cell. 27, 409\u2013425 (2015).","journal-title":"Cancer Cell."},{"key":"BFnrc2017111_CR92","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1084\/jem.20090004","volume":"206","author":"D Trageser","year":"2009","unstructured":"Trageser, D. et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J. Exp. Med. 206, 1739\u20131753 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR93","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature21076","volume":"542","author":"LN Chan","year":"2017","unstructured":"Chan, L. N. et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature 542, 479\u2013483 (2017).","journal-title":"Nature"},{"key":"BFnrc2017111_CR94","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/leu.2013.223","volume":"28","author":"DS Mangum","year":"2014","unstructured":"Mangum, D. S. et al. VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia 28, 216\u2013220 (2014).","journal-title":"Leukemia"},{"key":"BFnrc2017111_CR95","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature01608","volume":"423","author":"H Jumaa","year":"2003","unstructured":"Jumaa, H. et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukemia. Nature 423, 452\u2013456 (2003).","journal-title":"Nature"},{"key":"BFnrc2017111_CR96","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/sj.onc.1209520","volume":"25","author":"M Sprangers","year":"2006","unstructured":"Sprangers, M. et al. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells. Oncogene 25, 5180\u20135186 (2006).","journal-title":"Oncogene"},{"key":"BFnrc2017111_CR97","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371, 1005\u20131015 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR98","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118, 3080\u20133087 (2011).","journal-title":"Blood"},{"key":"BFnrc2017111_CR99","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","volume":"124","author":"J Irving","year":"2014","unstructured":"Irving, J. et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 124, 3420\u20133430 (2014).","journal-title":"Blood"},{"key":"BFnrc2017111_CR100","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.194.7.927","volume":"194","author":"A Br\u00e4uninger","year":"2001","unstructured":"Br\u00e4uninger, A. et al. Survival and clonal expansion of mutating \u201cforbidden\u201d (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T cell lymphoma. J. Exp. Med. 194, 927\u2013940 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR101","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","volume":"184","author":"H Kanzler","year":"1996","unstructured":"Kanzler, H., K\u00fcppers, R., Hansmann, M. L. & Rajewsky, K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495\u20131505 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR102","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/leu.2008.304","volume":"23","author":"P Lu","year":"2009","unstructured":"Lu, P. et al. Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma. Leukemia 23, 807\u2013810 (2009).","journal-title":"Leukemia"},{"key":"BFnrc2017111_CR103","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/eji.200323765","volume":"33","author":"A Brauninger","year":"2003","unstructured":"Brauninger, A. et al. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur. J. Immunol. 33, 1593\u20131602 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnrc2017111_CR104","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage, K. J. et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102, 3871\u20133879 (2003).","journal-title":"Blood"},{"key":"BFnrc2017111_CR105","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1084\/jem.191.2.395","volume":"191","author":"B Jungnickel","year":"2000","unstructured":"Jungnickel, B. et al. Clonal deleterious mutations in the IKBA gene in the malignant cells in Hodgkin's lymphoma. J. Exp. Med. 191, 395\u2013402 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR106","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz, R. et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J. Exp. Med. 206, 981\u2013989 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrc2017111_CR107","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676\u20131679 (2008).","journal-title":"Science"},{"key":"BFnrc2017111_CR108","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115\u2013119 (2011).","journal-title":"Nature"},{"key":"BFnrc2017111_CR109","first-page":"549","volume":"60","author":"S Joos","year":"2000","unstructured":"Joos, S. et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 60, 549\u2013552 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc2017111_CR110","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"I Melzner","year":"2005","unstructured":"Melzner, I. et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105, 2535\u20132542 (2005).","journal-title":"Blood"},{"key":"BFnrc2017111_CR111","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","volume":"114","author":"A Mottok","year":"2009","unstructured":"Mottok, A. et al. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood 114, 4503\u20134506 (2009).","journal-title":"Blood"},{"key":"BFnrc2017111_CR112","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1038\/bcj.2014.61","volume":"4","author":"PD Nagel","year":"2014","unstructured":"Nagel, P. D. et al. KIT mutations in primary mediastinal B-cell lymphoma. Blood Cancer J. 4, e241 (2014).","journal-title":"Blood Cancer J."},{"key":"BFnrc2017111_CR113","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","volume":"106","author":"C Mancao","year":"2005","unstructured":"Mancao, C. et al. Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106, 4339\u20134344 (2005).","journal-title":"Blood"},{"key":"BFnrc2017111_CR114","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","volume":"106","author":"D Bechtel","year":"2005","unstructured":"Bechtel, D. et al. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood 106, 4345\u20134350 (2005).","journal-title":"Blood"},{"key":"BFnrc2017111_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-5378.2003.00118.x","volume":"8","author":"M Asahi","year":"2003","unstructured":"Asahi, M. et al. Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter 8, 1\u201314 (2003).","journal-title":"Helicobacter"},{"key":"BFnrc2017111_CR116","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","volume":"129","author":"K Krysiak","year":"2017","unstructured":"Krysiak, K. et al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood 129, 473\u2013483 (2017).","journal-title":"Blood"},{"issue":"6","key":"BFnrc2017111_CR117","doi-asserted-by":"publisher","first-page":"718","DOI":"10.15252\/embj.201695495","volume":"36","author":"Leonie Smeenk","year":"2017","unstructured":"Smeenk, L. et al. Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia. EMBO J. 36, 718\u2013735.","journal-title":"The EMBO Journal"},{"issue":"1","key":"BFnrc2017111_CR118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","volume":"210","author":"Robbert Hoogeboom","year":"2013","unstructured":"Hoogeboom, R. et al. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J. Exp. Med. 210, 59\u201370.","journal-title":"The Journal of Experimental Medicine"},{"key":"BFnrc2017111_CR119","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","volume":"98","author":"ER Quinn","year":"2001","unstructured":"Quinn, E. R. et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98, 3745\u20133749 (2001).","journal-title":"Blood"},{"key":"BFnrc2017111_CR120","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","volume":"330","author":"J Parsonnet","year":"1994","unstructured":"Parsonnet, J. et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267\u20131271 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR121","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","volume":"162","author":"DF Robbiani","year":"2015","unstructured":"Robbiani, D. F. et al. Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell 162, 727\u2013737 (2015).","journal-title":"Cell"},{"key":"BFnrc2017111_CR122","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M D\u00fchren-von Minden","year":"2012","unstructured":"D\u00fchren-von Minden, M. et al. Chronic lymphocytic leukemia is driven by antigen independent cell-autonomous signalling. Nature 489, 309\u2013312 (2012).","journal-title":"Nature"},{"key":"BFnrc2017111_CR123","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/ncomms15746","volume":"8","author":"C Minici","year":"2017","unstructured":"Minici, C. et al. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukemia. Nat. Commun. 8, 15746 (2017).","journal-title":"Nat. Commun."},{"key":"BFnrc2017111_CR124","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","volume":"373","author":"E Tiacci","year":"2015","unstructured":"Tiacci, E. et al. Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N. Engl. J. Med. 373, 1733\u20131747 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR125","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1039\/C0OB00441C","volume":"9","author":"J Kuil","year":"2011","unstructured":"Kuil, J., Fischer, M. J., de Mol, N. J. & Liskamp, R. M. Cell permeable ITAM constructs for the modulation of mediator release in mast cells. Org. Biomol. Chem. 9, 820\u2013833 (2011).","journal-title":"Org. Biomol. Chem."},{"key":"BFnrc2017111_CR126","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cellsig.2006.07.023","volume":"19","author":"C Pracht","year":"2007","unstructured":"Pracht, C., Minguet, S., Leitges, M., Reth, M. & Huber, M. Association of protein kinase C-delta with the B cell antigen receptor complex. Cell Signal. 19, 715\u2013722 (2007).","journal-title":"Cell Signal."},{"key":"BFnrc2017111_CR127","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1128\/MCB.01699-13","volume":"34","author":"A Limnander","year":"2014","unstructured":"Limnander, A. et al. Protein kinase C\u03b4 promotes transitional B cell-negative selection and limits proximal B cell receptor signaling to enforce tolerance. Mol. Cell. Biol. 34, 1474\u20131485 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc2017111_CR128","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/09537104.2013.868877","volume":"26","author":"D Bhavanasi","year":"2015","unstructured":"Bhavanasi, D., Kostyak, J. C., Swindle, J., Kilpatrick, L. E. & Kunapuli, S. P. CGX1037 is a novel PKC isoform delta selective inhibitor in platelets. Platelets 26, 2\u20139 (2015).","journal-title":"Platelets"},{"key":"BFnrc2017111_CR129","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.167.6.3391","volume":"167","author":"MK Pathak","year":"2001","unstructured":"Pathak, M. K. & Yi, T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167, 3391\u20133397 (2001).","journal-title":"J. Immunol."},{"key":"BFnrc2017111_CR130","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.4049\/jimmunol.0902844","volume":"184","author":"R Brooks","year":"2010","unstructured":"Brooks, R. et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 184, 3582\u20133589 (2010).","journal-title":"J. Immunol."},{"key":"BFnrc2017111_CR131","doi-asserted-by":"publisher","first-page":"e88544","DOI":"10.1172\/jci.insight.88544","volume":"1","author":"N Srivastava","year":"2016","unstructured":"Srivastava, N. et al. A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome. JCI Insight 1, e88544 (2016).","journal-title":"JCI Insight"},{"key":"BFnrc2017111_CR132","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/ng1673","volume":"37","author":"T Vang","year":"2005","unstructured":"Vang, T. et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37, 1317\u20131319 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrc2017111_CR133","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1182\/blood-2012-01-403162","volume":"119","author":"R Negro","year":"2012","unstructured":"Negro, R. et al. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. Blood 119, 6278\u20136287 (2012).","journal-title":"Blood"},{"key":"BFnrc2017111_CR134","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood-2012-08-450221","volume":"121","author":"SJ Hebbring","year":"2013","unstructured":"Hebbring, S. J. et al. Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia. Blood 121, 237\u2013238 (2013).","journal-title":"Blood"},{"key":"BFnrc2017111_CR135","doi-asserted-by":"publisher","first-page":"aaf7153","DOI":"10.1126\/sciimmunol.aaf7153","volume":"1","author":"J-N Schickel","year":"2016","unstructured":"Schickel, J.-N. et al. PTPN22 inhibition resets defective human central B cell tolerance. Sci. Immunol. 1, aaf7153 (2016).","journal-title":"Sci. Immunol."},{"key":"BFnrc2017111_CR136","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nchembio.916","volume":"8","author":"T Vang","year":"2012","unstructured":"Vang, T. et al. LYP inhibits T-cell activation when dissociated from CSK. Nat. Chem. Biol. 8, 437\u2013446 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrc2017111_CR137","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943\u20131947 (1997).","journal-title":"Science"},{"key":"BFnrc2017111_CR138","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2010-09-309864","volume":"117","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood 117, 6702\u20136713 (2011).","journal-title":"Blood"},{"key":"BFnrc2017111_CR139","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1073\/pnas.1202810109","volume":"109","author":"H Jo","year":"2012","unstructured":"Jo, H. et al. Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc. Natl Acad. Sci. USA 109, 10581\u201310586 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2017111_CR140","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nchembio.190","volume":"5","author":"G Molina","year":"2009","unstructured":"Molina, G. et al. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat. Chem. Biol. 5, 680\u2013687 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrc2017111_CR141","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/15384047.2015.1040961","volume":"16","author":"CS Hong","year":"2015","unstructured":"Hong, C. S. et al. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential. Cancer Biol. Ther. 16, 821\u2013833 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"BFnrc2017111_CR142","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF02899046","volume":"51","author":"Y Iwama","year":"1986","unstructured":"Iwama, Y. & Eguchi, M. Quantitative evaluation of leukemic mitochondria with a computer-controlled image analyzer. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 51, 375\u2013384 (1986).","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"BFnrc2017111_CR143","first-page":"1224","volume":"8","author":"GJ Kaspers","year":"1994","unstructured":"Kaspers, G. J. et al. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Leukemia 8, 1224\u20131229 (1994).","journal-title":"Leukemia"},{"key":"BFnrc2017111_CR144","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B. J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038\u20131042 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2017111_CR145","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","volume":"26","author":"MS Zabriskie","year":"2014","unstructured":"Zabriskie, M. S. et al. BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell. 26, 428\u2013442 (2014).","journal-title":"Cancer Cell."},{"key":"BFnrc2017111_CR146","doi-asserted-by":"publisher","first-page":"E4030","DOI":"10.1073\/pnas.1702489114","volume":"114","author":"O Schwartzman","year":"2017","unstructured":"Schwartzman, O. et al. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome. Proc. Natl Acad. Sci. USA 114, E4030\u2013E4039 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2017111_CR147","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1182\/blood-2015-04-639138","volume":"126","author":"CL Jones","year":"2015","unstructured":"Jones, C. L. et al. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood 126, 2202\u20132212 (2015).","journal-title":"Blood"},{"key":"BFnrc2017111_CR148","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","volume":"19","author":"RR Hardy","year":"2001","unstructured":"Hardy, R. R. & Hayakawa, K. B cell development pathways. Annu. Rev. Immunol. 19, 595\u2013621 (2001).","journal-title":"Annu. Rev. Immunol."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc.2017.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc.2017.111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrc.2017.111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrc.2017.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:23:22Z","timestamp":1684455802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc.2017.111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFnrc2017111"],"URL":"https:\/\/doi.org\/10.1038\/nrc.2017.111","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]},"assertion":[{"value":"5 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research in M.M.'s laboratory to elucidate the mechanisms of autoimmunity checkpoints concept activation in B cell malignancies and feasibility of drug-targeting is currently supported by research funding from AbbVie Inc. and Pfizer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}